More than 10 pharmaceutical companies disclosed their semi-annual results, and CRO companies performed well

[Pharmaceutical Network Industry News] On August 23, more than 10 pharmaceutical companies announced their semi-annual results, including Microchip Bio, Hisun Pharmaceutical, Tianxin Pharmaceutical, Tongce Medical, Kyushu, Medicilon, St.
Jitang, Sanyou Medical, Gongdong Medical, Weir Pharmaceutical, Weigao Orthopedics,
etc.

Judging from the semi-annual report data disclosed by these pharmaceutical companies, more than half of the pharmaceutical companies such as Hisun Pharmaceutical, Medicilon, Sanyou Medical, and Gongdong Medical achieved a year-on-year increase in net profit.
Among them, the CRO company Medicilon performed relatively well.
In the first half of the year, the increase in net profit reached 43.
77%
.

However, there are also some pharmaceutical companies such as Kyushu and Weigao Orthopedics, whose performance has declined due to various challenges such as the epidemic
.

Medicilon: Net profit increased by 43.
77% year-on-year.
During the reporting period, Medicilon achieved operating income of 743 million yuan, a year-on-year increase of 53.
16%; net profit attributable to shareholders of listed companies was 163 million yuan, a year-on-year increase of 43.
77%
.

According to the company, the performance growth is mainly due to the company's continuous increase in R&D investment, improving R&D capabilities and service quality, and enhancing and broadening its ability to undertake orders by leveraging its comprehensive service advantages in preclinical integration
.

At the same time, the company actively cooperated with the epidemic prevention, organized employees to resume work and production in an orderly manner during the epidemic, and the R&D personnel arrival rate from about 70% in the early stage of epidemic prevention and control to about 80% in the later stage of epidemic prevention and control ensured the steady growth of operating income
.

 　　Hisun Pharmaceutical: Net profit increased by 13.
88% year-on-year Hisun Pharmaceutical's semi-annual report shows that the company overcame the impact of the epidemic as a whole and achieved operating income of 5.
737 billion yuan; net profit attributable to owners of the parent company was 319 million yuan, a year-on-year increase of 13.
88%
.

 　　Gongdong Medical: Net profit increased by 18.
92% year-on-year.
In the first half of the year, Gongdong Medical achieved operating income of 799 million yuan, a year-on-year increase of 38.
70%; net profit attributable to shareholders of listed companies was 211 million yuan, a year-on-year increase of 18.
92%
.

 　　Sanyou Medical: Net profit increased by 8.
79% year-on-year.
Sanyou Medical achieved operating income of 297 million yuan from January to June 2022, a year-on-year increase of 13.
68%.
The net profit attributable to shareholders of the listed company was 76.
6562 million yuan, an increase of 8.
79% year-on-year
.

 　　Will Pharmaceutical: Net profit increased by 7.
55% year-on-year From January 1, 2022 to June 30, 2022, Will Pharmaceutical achieved operating income of 588 million yuan, a year-on-year increase of 21.
31%, and a net profit of 60.
7624 million yuan, a year-on-year increase of 7.
55 %
.

 　　Weigao Orthopedics: Net profit increased by 7.
81% year-on-year In the first half of the year, Weigao Orthopedics achieved operating income of 1.
105 billion yuan, a year-on-year increase of 0.
9%, and realized a net profit attributable to shareholders of the listed company of 398 million yuan, a year-on-year increase of 7.
81%
.

 　　Chenxin Pharmaceutical: Net profit increased by 0.
74% year-on-year Chenxin Pharmaceutical achieved operating income of 1.
863 billion yuan from January to June 2022, a year-on-year increase of 1.
74%, and net profit attributable to shareholders of listed companies was 184 million yuan, a year-on-year increase of 0.
74%
.

 　　Tianxin Pharmaceutical: Net profit decreased by 4.
4% year-on-year In the first half of 2022, Tianxin Pharmaceutical's operating income was approximately 1.
241 billion yuan, a year-on-year decrease of 2.
05%; the net profit attributable to shareholders of listed companies was approximately 401 million yuan, a year-on-year decrease of 4.
4%
.

 　　Tongce Medical: Net profit decreased by 15.
73% year-on-year In the first half of the year, Tongce Medical achieved operating income of 1.
318 billion yuan, a year-on-year increase of 0.
05%; net profit attributable to shareholders of listed companies was 296 million yuan, a year-on-year decrease of 15.
73%
.

 　　Jointown: Net profit decreased by 41.
58% year-on-year In the first half of the year, Jointown achieved operating income of 67.
984 billion yuan, a year-on-year increase of 9.
69%; net profit attributable to shareholders of listed companies was 1.
269 billion yuan, a year-on-year decrease of 41.
58%
.

 　　Shengji Church: The net profit loss is about 95.
73 million yuan.
According to the semi-annual performance report released by Shengji Church, the operating income in the first half of 2022 is about 1.
379 billion yuan, a year-on-year increase of 33.
6%; the net profit loss attributable to shareholders of the listed company is about 95.
73 million yuan Yuan
.

 　　Chipchip Bio: Net profit of about -19.
29 million yuan Chipchip Bio's 2022 semi-annual report shows that operating income is 216 million yuan, a year-on-year increase of 17.
79%
.

The net loss attributable to shareholders of the listed company was 19.
2883 million yuan
.

The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 22.
5834 million yuan
.

 　　Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.